John Hamilton
👤 SpeakerAppearances Over Time
Podcast Appearances
replaced every member of a similar committee that advises the federal government on autism research priorities.
The new group plans to offer alternative guidance.
It includes two former directors of the National Institute of Mental Health, leading academic scientists and doctors, a former congressman, and members of advocacy organizations.
Most of them have criticized Kennedy's efforts to link vaccines and autism, as well as his support for ideas about the condition that lack credible scientific backing.
The independent committee plans to hold its first public meeting on March 19 in Washington.
Researchers set out to shrink an AI model that acts like a part of the brain's visual system.
When they started, the model used 60 million variables.
But Ben Cowley of Cold Spring Harbor Laboratory says the team was able to make a streamlined version that had just 10,000 variables.
And that is incredibly small.
This is something we could send in a tweet or an email.
Cowley says the key was finding redundant or unnecessary elements and applying statistical techniques like those used to compress digital photos.
The results suggest that a type of AI system that now requires a torrent of electricity could get by with just a trickle.
The drug is a form of vitamin B called leucovorin.
It's approved for patients undergoing cancer chemotherapy.
In September, FDA Commissioner Dr. Marty McCary suggested Leucovorin might also help many children with autism.
We are going to change the label to make it available.
Hundreds of thousands of kids, in my opinion, will benefit.
The label hasn't changed yet, but the announcement helped create a run on FDA-approved Leucovorin tablets, which were already in short supply.